Medicine overview
Description
Composition
Each Pigmo capsule contains Psoralea (Psoralia corylifolia) 218.75mg, Chebulic Myrobalan (Terminalia chebula) 250mg, and Ginger (Zingiber officinale) 31.25mg, formulated as a traditional Unani preparation.
Uses & Indications
Pigmo is indicated for vitiligo (leucoderma), a condition involving patchy loss of skin pigmentation. The Unani formulation combines Psoralea, Chebulic Myrobalan, and Ginger, ingredients traditionally used together to support skin repigmentation.
Dosage & Administration
The typical adult dose is 1 to 2 capsules twice daily, or as prescribed by a physician. Treatment for vitiligo is generally long-term, and consistent use under medical supervision is advised for the best outcome.
Precautions & Side Effects
No significant side effects have been reported at the recommended therapeutic dose, and no known contraindications have been identified for this formulation. As with any vitiligo treatment, results vary by individual and by the extent and duration of pigment loss, and a physician's guidance is recommended for realistic expectations and monitoring. Pregnant or breastfeeding individuals, and those on other medication, should consult a physician before use, as formal safety data for these groups is not established for this specific product.
Storage & Safety
Store in a cool, dry place, protected from light. Keep out of reach of children. Discontinue use and consult a physician if any unexpected reaction occurs.
Frequently Asked Questions
Q: What is Pigmo used for?
A: Pigmo is used to treat vitiligo (leucoderma), a skin condition marked by patches of pigment loss.
Q: What are the active ingredients in Pigmo?
A: Each capsule contains three Unani herbal ingredients: Psoralea (Psoralia corylifolia) 218.75mg, Chebulic Myrobalan (Terminalia chebula) 250mg, and Ginger (Zingiber officinale) 31.25mg.
Q: What is the recommended dosage?
A: The typical adult dose is 1 to 2 capsules twice daily, or as directed by a physician.
Q: How long does it take to see results?
A: Vitiligo treatment is generally long-term, and repigmentation happens gradually; consistent use under a physician's guidance is recommended, and individual response times vary.
Q: Are there any side effects?
A: No significant side effects have been reported at the recommended dose, and no known contraindications have been identified for this formulation.
Q: Can pregnant or breastfeeding women take Pigmo?
A: Formal safety data for pregnant or breastfeeding individuals is not established for this specific product, so a physician should be consulted before use in these situations.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.
